NEW YORK (GenomeWeb) – Singulex announced today that it has signed an agreement giving EMD Millipore, a unit of Germany's Merck KGaA, the rights to control and manage its life science research business, which includes the company's single-molecule counting (SMC) technology.

The SMC technology enables the detection of single molecules such as proteins and metabolites in complex biological samples. It is the basis for Singulex's research-use-only Erenna instrument, which can detect single molecules down to the femtogram level.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

NPR reports that Turkish high school students will no longer study evolution.

Researchers report they sequenced and identified plant species in an "al fresco" laboratory.

An Australian team searches for genetic alterations linked to depression in hopes of developing personalized treatments, the Sydney Morning Herald reports.

In PNAS this week: host contributors to typhoid fever risk, effects of obesity-related variants near TMEM18, and more.